8-K: Arteris Reports Record ACV Plus Royalties, Provides Optimistic 2025 Guidance

Arteris announces strong Q4 and full-year 2024 results, driven by demand for its system IP in AI and automotive sectors, and provides encouraging guidance for 2025.

Summary

• Arteris, Inc. announced its financial results for the fourth quarter and full year 2024, along with guidance for the first quarter and full year 2025.
• In Q4 2024, Arteris achieved a record Annual Contract Value (ACV) plus royalties of $65.1 million, a 16% increase year-over-year.
• The company's revenue for Q4 2024 was $15.5 million, up 24% year-over-year.
• The remaining performance obligation (RPO) reached $88.4 million, a 22% increase year-over-year.
• Arteris reported an operating loss of $7.1 million for Q4 2024, an improvement from the $9.2 million loss in Q4 2023.
• For the full year 2024, Arteris' revenue was $57.7 million, an 8% increase year-over-year.
• The operating loss for the full year 2024 was $31.6 million, compared to $35.1 million in 2023.
• Arteris signed 14 new customers in 2024, including two major automotive OEMs.
• For Q1 2025, Arteris expects ACV plus royalties to be between $65.5 million and $67.5 million, and revenue between $15.7 million and $16.1 million.
• The company anticipates a non-GAAP operating loss between $3.0 million and $4.0 million and free cash flow between $(2.0) million and $2.0 million for Q1 2025.
• For the full year 2025, Arteris projects ACV plus royalties between $73.0 million and $77.0 million, and revenue between $66.0 million and $70.0 million.
• The company forecasts a non-GAAP operating loss between $8.5 million and $12.5 million and free cash flow between $1.0 million and $7.0 million for the full year 2025.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with record ACV, revenue growth, and improved operating loss. The guidance for 2025 is also encouraging, suggesting continued growth and progress towards profitability. However, the company is still reporting an operating loss and net loss, which tempers the overall sentiment.

Positives

• Record ACV plus royalties indicate strong demand for Arteris' products.
• Revenue growth demonstrates the company's ability to capitalize on market opportunities.
• Increase in RPO suggests future revenue visibility.
• New customer acquisitions, especially in the automotive sector, expand Arteris' market reach.
• Strategic expansion into the microcontroller space with Infineon licensing is a positive development.
• The release of FlexGen smart NoC IP has the potential to improve engineer productivity and lower power consumption.
• Improved operating loss compared to the previous year indicates progress towards profitability.
• Positive free cash flow guidance for 2025 suggests improved financial health.

Negatives

• The company is still reporting an operating loss, although it is improving.
• The company is still reporting a net loss, although it is improving.
• Free cash flow was negative for the full year 2024.

Risks

• The company faces significant competition from larger companies and third-party providers.
• Arteris has a history of net losses.
• The company's success depends on semiconductor companies incorporating its solutions into their end products.
• Macro-economic conditions and geopolitical conflicts could adversely impact the company.
• The company is exposed to regulatory, operational, financial and political risks due to its dependence on international customers and operations.
• The company's ability to protect its proprietary technology and inventions is crucial.
• Disruptions in networks or security breaches could harm the company's operations.
• Risks associated with doing business in China could impact the company.

Future Outlook

Arteris anticipates continued growth in ACV plus royalties and revenue for both Q1 and full year 2025. The company expects to reduce its non-GAAP operating loss and achieve positive free cash flow for the full year 2025.

Management Comments

• In the fourth quarter of 2024, we achieved a record Annual Contract Value plus royalties of $65.1 million, driven by strong demand for our commercial semiconductor System IP products, particularly in AI-driven enterprise computing and automotive SoCs said K. Charles Janac, President and CEO of Arteris.
• As AI adoption accelerates across data centers, autonomous driving, and edge devices, the growing complexity of both high performance and traditional technologies like MCUs is fueling demand for the efficiency enabled by Arteris networks-on-chip IP technology, contributing to new customer wins, and expanded partnerships.
• With a robust product pipeline and deepening relationships with top-tier technology companies, we believe we are well-positioned to capitalize on exciting high-growth opportunities including Generative AI and Autonomous Driving, concluded Janac.

Industry Context

Arteris' results reflect the increasing demand for system IP in the semiconductor industry, particularly in high-growth areas like AI, automotive, and edge computing. The company's focus on network-on-chip (NoC) technology positions it well to capitalize on the growing complexity of SoC designs.

Comparison to Industry Standards

• Arteris competes with companies like Arm, Cadence Design Systems, and Synopsys in the system IP market.
• The 16% year-over-year growth in ACV plus royalties is a strong indicator of Arteris' competitive position.
• The company's focus on AI and automotive applications aligns with industry trends and growth opportunities.
• The licensing of Arteris interconnect to Infineon demonstrates the company's ability to secure key partnerships with leading semiconductor companies.
• The release of FlexGen smart NoC IP positions Arteris as an innovator in the NoC design space.

Stakeholder Impact

• Shareholders will likely react positively to the record ACV and revenue growth.
• Employees may be encouraged by the company's positive outlook and growth prospects.
• Customers will benefit from Arteris' continued innovation and product development.
• Suppliers may see increased demand for their products and services as Arteris grows.
• Creditors may view Arteris as a more creditworthy borrower due to its improved financial performance.

Key Dates